Saara Koskela

TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity (2024)

Genes and Immunity

Langguth Miriam, Maranou Eleftheria, Koskela Saara A., Elenius Oskar, Kallionpää Roosa E., Birkman Eva-Maria, Pulkkinen Otto I., Sundvall Maria, Salmi Marko, Figueiredo Carlos R.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

From antimicrobial to anticancer: the pioneering works of Prof Luiz Rodolpho Travassos on bioactive peptides (2023)

Brazilian Journal of Microbiology

Koskela Saara A, Figueiredo Carlos R

(A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä)

Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities (2023)

Journal of Pathology

Matareed Maisoon, Maranou Eleftheria, Koskela Saara A, Mehmood Arfa, Kalirai Helen, Coupland Sarah E, Figueiredo Carlos R

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

PIM kinases regulate early human Th17 cell differentiation (2023)

Cell Reports

Buchacher Tanja, Shetty Ankitha, Koskela Saara A., Smolander Johannes, Kaukonen Riina, Sousa Antonio G. G., Junttila Sini, Laiho Asta, Rundquist Olof, Lonnberg Tapio, Marson Alexander, Rasool Omid, L. Laura, Lahesmaa Riitta

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Epigenetic control of CD1D expression as a mechanism of resistance to immune checkpoint therapy in poorly immunogenic melanomas (2023)

Frontiers in Immunology

Wang Mona M, Koskela Saara A, Mehmood Arfa, Langguth Miriam, Maranou Eleftheria, Figueiredo Carlos R

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Saara

Koskela

Contact

Publications

Sort by:

TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity (2024)

From antimicrobial to anticancer: the pioneering works of Prof Luiz Rodolpho Travassos on bioactive peptides (2023)

Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities (2023)

PIM kinases regulate early human Th17 cell differentiation (2023)

Epigenetic control of CD1D expression as a mechanism of resistance to immune checkpoint therapy in poorly immunogenic melanomas (2023)